Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 1
2011 1
2013 1
2015 1
2017 2
2018 4
2019 5
2020 4
2021 8
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Management of patients with lower-risk myelodysplastic syndromes.
Brunner AM, Leitch HA, van de Loosdrecht AA, Bonadies N. Brunner AM, et al. Among authors: bonadies n. Blood Cancer J. 2022 Dec 14;12(12):166. doi: 10.1038/s41408-022-00765-8. Blood Cancer J. 2022. PMID: 36517487 Free PMC article. Review.
Inflammasome Activation in Myeloid Malignancies-Friend or Foe?
Andina N, Bonadies N, Allam R. Andina N, et al. Among authors: bonadies n. Front Cell Dev Biol. 2022 Jan 27;9:825611. doi: 10.3389/fcell.2021.825611. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35155452 Free PMC article. Review.
Current status and trends in the diagnostics of AML and MDS.
Shumilov E, Flach J, Kohlmann A, Banz Y, Bonadies N, Fiedler M, Pabst T, Bacher U. Shumilov E, et al. Among authors: bonadies n. Blood Rev. 2018 Nov;32(6):508-519. doi: 10.1016/j.blre.2018.04.008. Epub 2018 Apr 27. Blood Rev. 2018. PMID: 29728319 Review.
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.
Chanias I, Stojkov K, Stehle GT, Daskalakis M, Simeunovic H, Njue LM, Schnegg-Kaufmann AS, Porret NA, Allam R, Rao TN, Benz R, Ruefer A, Schmidt A, Adler M, Rovo A, Balabanov S, Stuessi G, Bacher U, Bonadies N, On Behalf Of The Swiss Mds Study Group. Chanias I, et al. Among authors: bonadies n. Cancers (Basel). 2021 Jun 30;13(13):3296. doi: 10.3390/cancers13133296. Cancers (Basel). 2021. PMID: 34209457 Free PMC article. Review.
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity.
Bombaci G, Sarangdhar MA, Andina N, Tardivel A, Yu EC, Mackie GM, Pugh M, Ozan VB, Banz Y, Spinetti T, Hirzel C, Youd E, Schefold JC, Taylor G, Gazdhar A, Bonadies N, Angelillo-Scherrer A, Schneider P, Maslowski KM, Allam R. Bombaci G, et al. Among authors: bonadies n. Life Sci Alliance. 2022 Mar 7;5(6):e202101226. doi: 10.26508/lsa.202101226. Print 2022 Jun. Life Sci Alliance. 2022. PMID: 35256513 Free PMC article.
Guideline-based indicators for adult patients with myelodysplastic syndromes.
Stojkov K, Silzle T, Stussi G, Schwappach D, Bernhard J, Bowen D, Čermák J, Dinmohamed AG, Eeltink C, Eggmann S, Fenaux P, Germing U, Haschke M, Hellstrom-Lindberg E, Heger M, van de Loosdrecht AA, Passweg J, Pfeilstöcker M, Platzbecker U, Malcovati L, de Almeida AM, Mittelman M, Morgenthaler C, Steensma DP, Santini V, Stauder R, Symeonidis A, Schär S, Maddox C, de Witte T, Bohlius J, Bonadies N. Stojkov K, et al. Among authors: bonadies n. Blood Adv. 2020 Aug 25;4(16):4029-4044. doi: 10.1182/bloodadvances.2020002314. Blood Adv. 2020. PMID: 32841339 Free PMC article.
34 results